Divergence in the approach to tumor necrosis factor α-inhibitor recipients with coccidioidomycosis

Ashley L. Garrett, Stephen S. Cha, Elizabeth Wack, Janis E. Blair

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Background: Tumor necrosis factor α-inhibitors (TNFIs) have been associated with increased risk of certain fungal infections, including coccidioidomycosis. The optimal treatment approach to coccidioidomycosis in TNFI recipients is unknown. Methods: We constructed an anonymous, voluntary survey for practicing pulmonary and infectious disease physicians in the state of Arizona regarding approach to TNFI patients with coccidioidomycosis. Results: There is no current consensus on managing these patients. Conclusions: Further research is necessary to determine the optimal approach to TNFI recipients with coccidioidomycosis.

Original languageEnglish (US)
Pages (from-to)539-543
Number of pages5
Issue number4
StatePublished - Aug 1 2017


  • Biologic response modifiers
  • Coccidioides
  • Coccidioidomycosis
  • Infliximab
  • Tumor necrosis factor α-inhibitors
  • Valley fever

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Divergence in the approach to tumor necrosis factor α-inhibitor recipients with coccidioidomycosis'. Together they form a unique fingerprint.

Cite this